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Abstract
Background: The optimal care of persons with diabetes by general practitioners and family physicians (GP/FP) is
complex and requires multiple competencies. This is a fairly unrecognized key challenge in the healthcare systems.
In some cases, local and national Continuous Professional Development (CPD) initiatives target these challenges;
however there have been few international initiatives, possibly because challenges emerging from different studies
have not been linked across national boundaries. In this context, the authors have compiled data about gaps and/
or barriers inherent to GP/FP care of persons with type 2 diabetes from Austria, Canada, Germany and the United
Kingdom.
Methods: Secondary analyzes of pre-existing studies were conducted to identify challenges in the care of patients
with type 2 diabetes as faced by GPs/FPs. Two sources of data were reviewed: unpublished research data from
collaborating organizations and articles from a literature search (in English and German). Articles retrieved were
scanned by the research team for relevance to the study objectives and to extract existing gaps and barriers. The
identified challenges were then categorized along three major axes: (1) phase of the continuum of care {from
screening to management}; (2) learning domain {knowledge, skills, attitudes, behavior, context}; and (3) by country/
region. Compilation and categorization were performed by qualitative researchers and discrepancies were resolved
through discussion until concordance was achieved.
Results and discussion: Thirteen challenges faced by GPs/FPs in the care for patients with type 2 diabetes were
common in at least 3 of the 4 targeted countries/regions. These issues were found across the entire continuum of
care and included: pathophysiology of diabetes, diagnostic criteria, treatment targets assessment, drugs’ modes of
action, decision-making in therapies, treatment guidelines, insulin therapy, adherence, management of
complications, lifestyle changes, team integration, bureaucracy and third-party payers. The issues reported were not
restricted to the physicians’ knowledge, but also related to their skills, attitudes, behaviours and context.
Conclusions: This study revealed challenges faced by GPs/FPs when caring for patients with diabetes, which were
similar across international and health system borders. Common issues might be addressed more efficiently
through international educational designs, adapted to each country’s healthcare system, helping develop and
maintain physicians’ competencies.
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An estimated 260 million people are affected by type 2
diabetes worldwide and a further 7 million people
develop diabetes each year [1]. Serious consequences of
this disease include a life span that may be shortened by
5 to 10 years. Additionally, diabetes will account for
6.8% of global mortality in the 20-79 age group for the
year 2010 [1]. Furthermore, diabetes and its complica-
tions have been shown to have a significant effect on
the quality of life (QoL), including reduced mobility,
anxiety towards long-term consequences, and depression
[2]. The importance of QoL has been recognized not
only as an important outcome of diabetes care, but also
as an important factor in adherence to diabetes self-care
activities [3].
In addition, the cost of diabetes to the health care sys-
tem is increasingly important. The International Dia-
betes Federation (IDF) [1] reports that most countries
are predicted to spend between 5% and 13% of their
total healthcare dollars on diabetes in 2010. The IDF
expect the worldwide cost to treat and prevent diabetes
and its complications to total at least 376 billion US$ in
2010, and to exceed 490 billion US$ by 2030. The IDF
estimates that an average of 703 US$ per person will be
spent on diabetes in 2010 globally.
The high prevalence/incidence of type 2 diabetes and
its substantive effects on quality of life, social impact, and
economic costs point to the importance of assuring that
this disease is screened, diagnosed and managed expedi-
tiously and effectively. Currently, the majority of persons
with diabetes are diagnosed, treated, and managed by
General Practitioners (GPs) and Family Physicians (FPs)
as front line providers of care [4], rather than by a diabe-
tologist or an endocrinologist [5]. Optimal care in type 2
diabetes requires practitioners to be competent in com-
plexities of disease management as well as in patient
communication, counseling, and education, as adressing
patients’ psychological problems and barriers are believed
to improve diabetes oucomes [6]. FPs/GPs are therefore
required to master both physiological and psychosocial
approaches to the treatment and management of type 2
diabetes [6]; yet, research evidence shows that many are
challenged in doing so [6,7].
A large study covering 13 countries, including Germany
and the United Kingdom, found health care providers
lacked resources (skill, time and referral sources) for com-
monly reported psychosocial problems amongst diabetes
patients [6].
Additional studies have suggested that FPs/GPs
experience challenges in treating and managing diabetes
[8]. One study reported patients’ frustration about their
practitioners’ lack of understanding of their perspective,
as well as practitioners’ frustration with patients’ inabil-
ity to achieve objectives and argued that frustration
leads to decreased adherence and eventually, lower
health outcomes [9]. In another study, physicians,
despite acknowledging the psychosocial aspects of treat-
ment adherence, focused almost entirely their manage-
ment approach on blood glucose levels [10]. The same
study linked adherence to treatment regimes with
patient-provider communication [10]. Adherence is
important as it has been estimated that 20% of patients
had poor adherence (defined as taking incomplete medi-
cation at least 20% of the days) [11]. Another study
identified physicians’ lack of proactive intensification of
therapy as an important barrier to optimal management
of diabetes [12]. Less than optimal achievement of treat-
ment and risk factors targets [13,14], and gaps in diag-
nosis and initial management of diabetes [15] have also
been reported. There is also evidence indicating that
FPs/GPs are challenged when intensification of medica-
tion is required [7,13]. However, the majority of these
issues were studied solely in the context of a single
country.
Continuing Professional Development (CPD) programs
are fundamental to the development and maintenance of
physician competencies [16] and have been developed
and deployed locally to address the aforementioned
challenges. Cultural differences and different health sys-
tem contexts are likely to influence the precise nature of
clinical gaps and barriers in a given country, however it
is likely that similar challenges will arise in different
countries. Identifying the issues that are concurrently
rising across borders would allow CME providers to
deploy and coordinate international CME interventions.
Through international deployment, scarce resources can
be shared, and programs developed more efficiently.
The organizations represented by the authors of this
manuscript formed an international collaborative with
the goal of developing and disseminating international
educational initiatives to FPs and GPs, and of addressing
gaps and challenges in the care of persons with diabetes.
The collaborative regroups organizations from Canada,
Austria, Germany, and the United Kingdom. The overall
objective of this research, which represents the first step
of the international collaborative project, was to identify
similarities in the gaps and barriers of the four regions
that could be used to develop an international educa-
tional program. In order to achieve that, the following
two steps were undertaken:: firstly, international data
characterizing gaps and/or barriers inherent to FPs and
GPs care of persons with type 2 diabetes was compiled;
and secondly, the identified gaps and/or barriers were
categorized according to the phases in the continuum of
care (screening, diagnosis, treatment, management, refer-
ral) and the adapted domains of Bloom’s taxonomy of
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context).
Methods
Data collection
This article presents secondary post-hoc analyzes of pre-
existing studies, from two sources: literature reviews (in
English and German) and unpublished research data from
the co-authors’ organizations. The three studies of the co-
authors were developped and deployed independently, and
each used its own methodology, described later in this
section.
Literature Review
The English-language literature review included three data-
bases: Medline [18], EMBase [19] and the Education
Resources Information Centre (ERIC) [20]. The following
search keywords and logic were adapted and complemen-
ted when necessary for each database: Diabetes AND (Gaps
OR Barriers OR Needs Assessment OR Health Care Needs
OR Challenges) AND (Family Practice OR Family Medicine
OR General Practice). Search keywords were not restricted
to any particular field. Article abstracts were screened by
the research team for relevance to the study objectives.
The German-language literature review included the fol-
lowing literature databases: Medline [18], EMBase [19],
the Deutsches Institut für Medizinische Dokumentation
und Information (DIMDI) [21], the Zeitschriftendatenbank
(ZDB) [22] and the Current Contents Medizin (ccMed)
Database [23]. The following search keywords and logic
were adapted and complemented when necessary for each
database: Diabetes AND (Gaps OR Barriers OR Needs
Assessment OR Health Care Needs OR Challenges OR
Versorgungsforschung) AND (Hausarzt OR Arzt für Allge-
meinmedizin OR Praktischer Arzt OR Allgemeinmedizin).
Search keywords were not restricted to any particular
field. Article abstracts were scanned by the German
research team for relevance to the study objectives.
The search to identify gaps and barriers was limited to
articles published between 2007 and 2010 inclusively. Arti-
cles were included if they reported gaps, barriers or chal-
lenges encountered by FPs/GPs in the care of type 2
diabetes persons, but were not limited to needs assessments
per se, nor were they limited by the methodology used.
A r t i c l e sh a dt or e p o r to ng a p sa n db a r r i e r si na tl e a s to n eo f
the four geographical areas selected (Austria, Canada, Ger-
many and United Kingdom). Final selection of the articles
was performed by the co-authors and research assistants.
No formal quality appraisal of each methodology was
performed.
Definitions used
In CPD, a gap is defined as “the difference between the
present condition of the learner and the acceptable
norm“ [24]. Barriers are defined as “tangible or intangi-
ble obstructions that block, hinder, delay, deter, or inter-
fere with action, movement, progress, or development“
[25]. These definitions are widely recognized and have
become a standard in the CPD field.
Research data from co-authors
The European Institute for Medical and Scientific Educa-
tion’s Diabetes Needs Assessment (EIMSED-NA) con-
sisted of a detailed questionnaire covering the phases from
early diagnosis to management in the continuum of care
of type 2 diabetes. In Austria, Germany, and the United
Kingdom, the questionnaire was applied to a sample num-
ber of 100 GPs in each country via computer assisted tele-
phone interviews (25-30 minutes per interview) during
February 2009. Participants were purposively selected to
achieve a spread of the interviewees over the respective
countries. The results were statistically analysed and gra-
phically displayed for subsequent scientific review.
Secondary analysis of the BMJ’s Diabetes Needs Assess-
ment Tool (DNAT) Trial [26] was conducted by onExa-
mination, part of BMJ Group. Quantitative assessment of
knowledge gaps and qualitative analysis of actual changes
to practice as a result of the learning intervention was
conducted in a sample of 677 English and German speak-
ing physicians recruited for the online learning research
study in the field of diabetes (BMJ-GAP). Data was col-
lected during 2009. The responses to the test-items
within the DNAT were analysed and those that high-
lighted the most prominent knowledge gaps identified.
The subject matter of the test-items were classified and
grouped into common areas representing gaps in knowl-
edge. The initial data analysis of the DNAT trial was con-
ducted by independent statisticians and is reported
elsewhere [26].
The AXDEV Diabetes Needs Assessment (AXDEV-NA)
used a mixed-methods approach, combining both qualita-
tive (discussion groups) and quantitative (questionnaire)
data collection techniques to identify educational opportu-
nities for FPs/GPs in type 2 diabetes care [27]. The study
used a triangulated research design, where multiple data
collection methods are combined to examine the same
phenomena from different perspectives, strengthening the
trustworthiness and validity of the evidence [28,29]. The
study was conducted in 2008 and included 22 Physicians,
13 allied health professionals and 8 patients and covered
the whole continuum of care, from screening and testing,
to treatment and management.
Analysis
Articles identified by the literature review, as well as
internal reports from the EIMSED-NA, BMJ-GAP and
AXDEV-NA studies were reviewed by the interdisciplin-
ary research team to extract the gaps and barriers, as
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observed. Extraction was performed based on the defini-
tions of gaps and barriers provided above. The issues
listed were then compiled and closely related ones were
regrouped together, by experienced qualitative research-
ers, including co-authors PL and SM. Grouping was per-
formed by idenfication of direct synonyms, shared
terminology and/or evidence of a higher level theme.
Common gaps and barriers, i.e., observed in at least
three of the four countries, were selected and coded
according to the phase in the continuum of care (screen-
ing, diagnosis, treatment, management, referral, context)
and to whether the gap and/or barrier existed in physi-
cians’ knowledge, skills, attitudes, behavior, or in context,
as described in the original study(ies). In the continuum of
care categorization, context related refers to issues that are
not related to a phase of care in particular but may affect
any of the phases, while context related in the second clas-
sification refers to issues that are more systemic and not at
the individual level of the physician, such as re-imburse-
ment policies for example. Coders were experienced quali-
tative researchers, including co-authors PL and SM.
Discrepancies throughout the process were resolved
through discussion until concordance was achieved.
Results
Literature review
The search strategy in the English-language literature
review produced 136 references in Medline, 148 in
EmBase and 22 in ERIC, while the German-language lit-
erature review produced 72 references in Medline, 84 in
EmBase, 97 in DIMDI and 33 in ccmed. After the elimi-
nation of duplicates and the application of our research
criteria, 16 documents in English and 22 in German, in
which FPs/GPs from the identified countries faced gaps
or barriers providing optimal care of type 2 diabetes,
were retained for further evaluation.
Data extraction, compilation and classification
A total of 98 gaps and barriers were extracted from the
38 articles found in the English and German literature
reviews and the three studies from the co-authors. Simi-
lar issues were then grouped to produce a list of 31 gaps
and barriers, 13 of which were common in at least 3 of
the 4 targeted countries. Table 1 shows the classification
of these 31 gaps and barriers, highlighting the 13 that
were retained.
Gaps and barriers: Pathophysiology of Diabetes
Concerning the condition of diabetes, the EIMSED-NA
study revealed that FPs/GPs lacked exact knowledge of the
pathophysiology of diabetes. More precisely, the pathophy-
siology section of the study had questions on the topic of
pro-insulin, as well as on the effect of diabetes on the
pancreatic hormones, beta cell mass and adiponectin. This
was observed in the three regions covered by the
EIMSED-NA study, i.e., Austria, Germany and the UK.
Gaps and barriers: Diagnosis
Challenges in diagnosing diabetes were identified in the
UK [BMJ-GAP], Germany [BMJ-GAP] [EIMSED-NA],
and Canada [AXDEV-NA]. It was found that FPs/GPs
lacked exact knowledge of the diagnostic criteria and cut-
off points. According to the AXDEV-NA study, diagnosis
guidelines are perceived to change often because of fre-
quent updates, leading each Canadian health care organi-
zation to develop their own cut-off points. This result
shows that the application of diagnosis guidelines can not
be related solely to knowledge, but that attitudes have an
impact as well.
Gaps and barriers: Testing
It was found that treatment targets for risk factors
(HbA1c, blood pressure, LDL-C) were not being ade-
quately tested in the UK and Germany [BMJ-GAP,
EIMSED-NA], in Austria [EIMSED-NA], as well as in
Canada [AXDEV-NA]. In Canada, physicians overestimate
the level at which the targets are achieved, a tendency
that, when combined with the perception that such testing
is expensive, impractical and time consuming, leads FPs/
GPs to test less regularly [AXDEV-NA]. Studies report
that in Germany, HbA1c is tested in only 68% of patients
[30]. Furthermore, only 7.6% of diabetic persons reached
target blood pressure values of < 130/80 mm Hg, and tar-
get LDL-C < 100 mg/dL (< 2.6 mmol/L) was achieved in
only 15.8% of patients [31]. In Germany and the UK it was
reported that physicians lacked the skills required to edu-
cate patients how to monitor their glucose levels [BMJ-
GAP].
Gaps and barriers: Treatment
In Austria, Germany and the United Kingdom, it was
reported that FPs/GPs lack the exact knowledge of the
mode or mechanism of action of the different drugs they
prescribe [EIMSED-NA]. Additionally, the BMJ-GAP ana-
lysis showed, for the UK and Germany, that FPs/GPs lack
the ability to give clear explanations to the patients of how
the substances work.
When treating persons with type 2 diabetes, FPs/GPs in
all four targeted countries lacked the knowledge, skills
and attitude to optimize their decision-making related to
therapies [AXDEV-NA, EIMSED-NA]. Notably, FPs/GPs
lacked knowledge about new treatment strategies
recently added to guidelines [32], and did not feel compe-
tent in the correct and safe use of newly developed thera-
pies. They also lacked the confidence to prescribe new
treatments with which they are unfamiliar. Furthermore,
in the three targeted European countries, FPs/GPs lacked
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Country/Region Type
Phase of the
Continuum of
Care
Themes: Gaps
and barriers
Austria Canada Germany UK Knowledge Skill Attitude Behaviour Context References
Condition Pathophysiology
of diabetes
X X X X EIMSED-NA
Diagnosis Diagnosis criteria X X X X X AXDEV-NA, BMJ-GAP,
[47,48]
Pre-diabetes X X X BMJ-GAP, [43]
Lack of screening X X X X AXDEV-NA
Testing Assessment of
treatment
targets
X X X X X X AXDEV-NA, BMJ-GAP,
[30-32,40,49,50]
Treatment Explaining drugs’
modes of action
X X X X X BMJ-GAP, EIMSED-
NA, [48]
Decision-making
in therapies
X X X X X X X AXDEV-NA, BMJ-GAP,
EIMSED-NA,
[48,51-54]
Treatment
guidelines
X X X X EIMSED-NA,
[34,35,55]
Insulin therapy X X X X X X BMJ-GAP, EIMSED-
NA, [36,37,56]
Management Adherence X X X X X X X X AXDEV-NA, EIMSED-
NA, [38,39]
Management of
complications
X X X X X X X BMJ-GAP, EIMSED-
NA, [41,57-59]
Lifestyle changes X X X X X AXDEV-NA, BMJ-GAP,
[43,44,60]
Patient education X X X X AXDEV-NA-NA, BMJ-
GAP-GAP, [44]
Blood pressure
control
X X [61]
Tele-monitoring X X X [62]
Computerization
of management
XX X X [ 2 ]
Psychological care X X X X X X AXDEV-NA, [63]
Motivation for
long-term follow-
ups
X X X X AXDEV-NA
Interprofessional
teamwork
X X X [48]
Lack of secondary
support
X X [64]
Referral Suboptimal team
integration
X X X X X X BMJ-GAP, [45,47,48]
Context Bureaucracy X X X X X X AXDEV-NA, EIMSED-
NA
Long waiting lists X X [65]
Care for the
aboriginal
population
X X [40]
Access and cost X X [40,65,66]
Third party
payers
X X X X EIMSED-NA, [67]
Other Physicians’
resistance to
change
X X X [54]
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the recommendations of the diabetes associations
[EIMSED-NA]. Guidelines were perceived as contradic-
tory, leading physicians to rely on treatment strategies
with which they are familiar [EIMSED-NA]. In Germany,
treatment guidelines were viewed with skepticism by
FPs/GPs, describing them as disregarding the individual
patient’s reality, especially in the case of patients with
multiple morbidities [33,34].
The use of insulin therapy was expressed as a challenge
for FPs/GPs in the three European countries [EIMSED-
NA]. More specifically, FPs/GPs did not feel competent
with insulin therapy, lacked knowledge on when to initi-
ate insulin therapy, and had challenges in maintaining
and adjusting insulin therapy [BMJ-GAP]. In Germany,
they were challenged in initiating an insulin therapy after
failure of the treatment with oral anti-diabetics [35] and
they lacked knowledge and skills regarding the appropri-
ate and individualized treatment of the elderly (largely
due to specificity in the guidelines regarding this group)
[36].
Gaps and barriers: Management and Monitoring
In the management and monitoring of type 2 diabetes,
FPs/GPs from all four countries were found to lack for-
mal training in counseling and coaching the patient
[AXDEV-NA] [EIMSED-NA] [37], a gap which has been
shown in the literature to impact on patient motivation
and adherence [9]. FPs/GPs had developed suboptimal
therapeutic relationships and they lacked the skills to
actively engage their patients in their health manage-
ment. They had little understanding of the psycho-social
issues underlying adherence, and appropriate tools to
assess potential for and actual adherence of their patients
is lacking [27]. In Germany, a lack in shared decision
making was reported [38]. Context issues may also play a
role in adherence as 57% of surveyed Canadians living
with diabetes said they do not comply with their pre-
scribed therapy due to cost and lack of access [39].
FPs/GPs from the three European countries found it
challenging to manage the complications of diabetes on
a long-term basis particularly neuropathies, pancreas
pathologies, diabetic foot [BMJ-GAP, EIMSED-NA], and
retinopathy [40]. In Germany [41], challenges in skills,
knowledge and attitudes were reported related to opti-
mal risk-assessment of the complications that a patient
might develop within a ten-year period. More specifi-
cally, there was a large disparity among the FPs/GPs in
their approach to risk-assessments, because FPs/GPs
were more inclined to go with their “gut feeling” than
making a decision based on knowledge, competence
and/or skills.
Results [AXDEV-NA, BMJ-GAP, [40,42]] also indicated
that British, Canadian and German FPs/GPs are not
being equipped to provide the appropriate patient educa-
tion to support patients in their efforts towards lifestyle
changes which would improve their condition. In Ger-
many, deficits were found in FP/GPs’ knowledge/skill/
attitude to motivate the patients for healthy lifestyle
changes [37]. Furthermore, in Canada [AXDEV-NA] and
Germany [43], it has been shown that FPs/GPs often put
their focus on curative care, thus reducing the emphasis
on and neglecting prevention.
Gaps and barriers: Referral
Suboptimal integration of the diabetic team during the
referral process was also reported in the United Kingdom,
Canada and Germany. More precisely, a gap was found in
the United Kingdom and Germany, relating to the subop-
timal use of the diabetic team, especially in referral to
other team members, e.g., specialist diabetic nurse, podia-
trist and dietician [BMJ-GAP]. In Germany, a lack of
resources and support for diabetic teams was reported as a
barrier, even though the potential of the paramedical per-
sonnel is high, which could mean that the resources are
there, but underutilized [44,45]. In Canada, suboptimal
integration between healthcare professionals was observed
[AXDEV-NA], as well as a lack of knowledge of other pro-
fessionals’ contributions [46].
Gaps and barriers: Context Issues
Context-related issues were also identified in all four
countries; more specifically, bureaucracy was named as a
barrier to optimal care. The high level of documentation
and effort required to update records were perceived as
problematic [EIMSED-NA]. Furthermore, FPs/GPs in
Table 1 Classification of the gaps/barriers identified in the targeted countries/region (Continued)
Lack of resources X X [54]
Physicians’ bias
towards obesity
X X [68]
Disengagement of
patients
X X X AXDEV-NA
Provider-Patient
relationships
X X X X AXDEV-NA
Note: Gaps and barriers presented in bold are those that were common in at least 3 of the 4 targeted countries.
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formally trained, including carrying out administrative
tasks [AXDEV-NA].
Additionally, third party payers were identified as con-
text-related issues in Austria, Germany and the United
Kingdom [EIMSED-NA]. Limitations set by health
insurance bodies/cost carriers on the prescribing of
newer (and in most cases, more expensive) drugs are
perceived as a barrier to optimal treatment by physicians
[EIMSED-NA].
Discussion
The consensus approach used for this research identified
needs, gaps and challenges that are similar in four different
countries/regions. Issues identified as common to the tar-
geted countries/regions might also be found in other
countries, but further research is required to confirm this.
These issues represent potential barriers to optimal health-
care that could be addressed by international educational
design. Although the international collaborative has lim-
ited its efforts to four countries/regions in its first phase of
activity, subsequent phases will be gradually enlarged to
include additional countries, and assess the feasibility of
using the same approach at a larger and more global level.
Education researchers designing needs assessments in
diabetes in these and other countries should be aware of
the most common gaps and barriers presented here, and
assure that they are included in future research designs.
International educational design would potentially
enable important economies of scale for education provi-
ders. The potential economies related to CME internatio-
nalization could be very important in optimizing resource
utilization in healthcare performance improvement, there-
fore evolving the applied standards in the CME field.
Reaching those highest standards is required to help physi-
cians and other health care providers achieve patient out-
comes compliant with the current best evidence, while
respecting existing healthcare budgets.
Cultural differences and different health system contexts
will require tailoring to ensure international applicability.
Nonetheless, education providers and designers should
verify the comparability of educational activities and look
for similarities that could be included in internationally
deployed programs. Reviews such as this one could be
instrumental in tailoring programs to local and regional
needs.
The approach presented here could also be used to
identify common gaps across countries in other thera-
peutic areas where internationalization of CPD activities
could also be beneficial.
Limitations
We acknowledge that our approach has some limitations.
Firstly, only recent manuscripts indexed in Medline,
EmBase, ERIC, DIMDI, ZDB or ccMED were included,
providing a selected sample of the literature. To supple-
ment our review, we drew upon three relevant sources of
data known to us. Secondly, needs, gaps and barriers that
were not identified in at least three of the four targeted
countries/regions were excluded from further analysis/
discussion and some of these issues could still hold inter-
national value. However our approach was designed to
identify issues clearly relevant to multiple countries.
Needs, gaps and barriers identified in less than three of
the targeted countries/regions, require more exploration
to determine if they are unique to one or two countries
or if they are international issues that have not yet been
identified in the other targeted countries. Thirdly, it can-
not be assumed that care is optimal in other areas where
gaps and barriers were not identified because emphasis
was put on detecting common challenges, at the expense
of areas in which care is excellent. Finally, cultural differ-
ences and different health system contexts might limit
the generalisability of the findings so these issues should
be investigated before designing local educational inter-
ventions in other areas.
Next steps
Following the literature-based needs assessment presented
in this manuscript, the international collaborative initiative
is pursuing its objective of internationalizing CME activ-
ities in the field of Diabetes, as it extends its efforts to
additional countries. An international educational program
is being developed to address five of the gaps and barriers
revealed by this review. This activity will focus on diagnos-
tic criteria, suboptimal integration of diabetic teams,
assessment of treatment targets, modes of action of drugs
and treatment guidelines. Those five gaps were selected
during a face-to-face meeting with all members of the
international collaborative, where members discussed and
ranked each of the 13 gaps identified according to their
reported importance and impact on patients’ outcomes.
Evaluation of the international educational program,
including the selection process of the five gaps to be tar-
geted, will be submitted for a separate publication.
Conclusions
A consensus approach identified needs, gaps and chal-
lenges faced by GPs/FPs when caring for persons with
type 2 diabetes that are similar in Austria, Canada,
Germany and the United Kingdom. These issues repre-
sent potential barriers to optimal healthcare that could
be addressed by international educational design. CPD
internationalization could quickly evolve the applied
standards in medical education, leading to the optimi-
zation of resource utilization in healthcare perfor-
mance improvement. Elevation of the CPD standards
will ultimately elevate the physicians’ performance in
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Page 7 of 9providing care to their diabetes patients, and conse-
quently contribute to better patient outcomes.
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